Business · 02/08/2013
Pfizer Withdraws FDA Approval of BEXTRA Tablets
The US Food and Drug Administration (FDA) is withdrawing approval of a new drug application for Pfizer's BEXTRA (valdecoxib) 10mg and 20mg tablets, following Pfizer's voluntary request to withdraw approval and waive a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →